Saach Pharmaceuticals Private Limited
Manimajra, Chandigarh
GST No. 04AAVCS9380D1ZW
Call 08048956206 65% Response Rate
Send Enquiry
Factsheet
Basic Information
| Nature of Business | Trader - Wholesaler/Distributor |
| Additional Business | Wholesale Business |
| Company CEO | Vikrant Chanana |
| Registered Address | SCO-405, Level 2, M. Market, Manimajra, New Motor Market, Chandigarh- 160101, Chandigarh, India |
| Total Number of Employees | Upto 10 People |
| GST Registration Date | 01-07-2017 |
| Legal Status of Firm | Limited Company |
| Annual Turnover | 1.5 - 5 Cr |
| GST Partner Name | Vikrant Chanana, Shikha |
Company USP
| Quality Measures / Testing Facilities | No |
Statutory Profile
| Import Export Code (IEC) | AAVCS9380D |
| Banker | CANARA BANKICICI BANK |
| GST No. | 04AAVCS9380D1ZW |
| CIN No. | U24232CH2015PTC035622 |
Packaging/Payment and Shipment Details
| Customized Packaging | Yes |
| Payment Mode | CashChequeDDOnlineBank Transfer |
| Shipment Mode | By Road |
Send us a Quick MessageDiscuss more about your requirement by contacting us now
Contact Us
Our Infrastructure
With the support of our wide and well functional infrastructural base, we are able to complete bulk and urgent consignments of our valued patrons in a limited time period. Sprawls over a huge area, this infrastructural unit is segregated into sub-divisions that include admin, quality testing, procurement, sales, processing, packaging, warehouse, transportation, etc. Our processing unit is well resourced with the most necessary equipments and managed by our veteran and capable workforce.
Terms & Conditions
Disclaimer: No drug is sold without a valid prescription
Our Mission
We aim to grow as a leading pharmaceutical company that cares for betterment of living beings and help them enhance health through our quality products.
Our Vision
With the vision of being the top pharmaceutical company in India, innovation andeffectiveness of our medicines are our main focus. “Our vision is to be a leadingpharmaceutical company in India and to become a significant global player byproviding high quality, affordable and innovative medicine and treatment."